Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

癌症研究和管理信息学技术的先进发展（U24临床试验可选）

• 批准号: 10447021
• 负责人: James Gregory Caporaso
• 金额: $ 73.72万
• 依托单位: NORTHERN ARIZONA UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-15 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10447021
• 关键词: Address; Advanced Development; Advanced Malignant Neoplasm; Architecture; Archives; Area; Bioinformatics; Cancer Detection; Cancer Prognosis; Clinical Trials; Collaborations; Colon Carcinoma; Communities; Computer software; Conflict (Psychology); Data; Data Pooling; Data Provenance; Decentralization; Deposition; Development; Diet; Ecosystem; Educational process of instructing; Educational workshop; Ensure; Environment; Environmental Exposure; Etiology; Galaxy; Genes; Genotype; Health; Human; Human Microbiome; Human body; Immune; Immune system; Improve Access; Individual; Informatics; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Metabolic; Metadata; Metagenomics; Methods; Modeling; Multiomic Data; Online Systems; Prognosis; Publications; R programming language; Reproducibility; Research; Research Personnel; Resources; Ribosomal RNA; Role; Running; Sampling; Series; Smoking Status; Systems Analysis; Taxonomy; Technology; The Cancer Genome Atlas; Time; Translating; Treatment Efficacy; Work; anticancer research; base; bioinformatics tool; cancer therapy; carcinogenesis; community engagement; data access; data integrity; data repository; data submission; driving force; epigenome; graphical user interface; improved; insight; malignant stomach neoplasm; metabolome; metabolomics; metagenome; metaproteomics; metatranscriptome; metatranscriptomics; microbial; microbiome; microbiome research; microbiota; microorganism; multiple omics; neoplasm resource; pathogenic microbe; pathogenic virus; preference; repository; research and development; skills; success; symposium; tool

In the past two decades, we have taken large strides towards understanding the role of the microbiota (the trillions of microorganisms inhabiting the human body) and the microbiome (their genes) in human health. Individual microbial or viral pathogens are implicated in the etiology of many cancers, including gastric, colon, and cervical cancer. Still more cancers likely arise from the interplay of many different microbial taxa, their metabolic activities, the host’s genotype and immune system activity, and factors such as host diet, current and former smoking status, and environmental exposures. We propose to advance cancer microbiome research through three specific aims. This work will be performed in the context of the popular QIIME 2 microbiome bioinformatics platform and the Qiita public microbiome data repository and pooled analysis system. In our first aim, we will improve access to cancer microbiome bioinformatics methods and data through the creation of a Galaxy interface for QIIME 2, improved support for working with QIIME 2 in the R programming language and Galaxy GUI ecosystem, popular for cancer research, the development of a resource for cancer microbiome pooled analysis, the development of a cancer- focused microbiome bioinformatics workshop series, and by making QIIME 2 and cancer microbiome data accessible from within the NCI Cloud Resources. Our second aim will develop a microbiome multi-omics bioinformatics platform driven by the needs of the cancer research community through creating QIIME 2 plugins for metabolomics, metatranscriptomics, metagenomics, and metaproteomics with developers working in these areas. Many important cancer microbiome projects have made advances by integrating these different data types, yet considerable technical hurdles remain to making microbiome multi-omics bioinformatics accessible by all researchers whose projects would benefit from these methods. To facilitate this, we will create a microbiome multi-omics bioinformatics developer conference, following the model of our recent Teaching and Developing QIIME 2 conference. Our third aim will improve the reproducibility of cancer microbiome bioinformatics methods, and the reliability of cancer microbiome bioinformatics results, by expanding several features related to tracking data provenance in QIIME 2, and helping users submit their microbiome multi-omics raw data to archival repositories. Much of this work will occur in collaboration with NCI Informatics Technology for Cancer Research (ITCR) and Cloud Resources project teams, several of whom we’re already beginning to collaborate with.

在过去的二十年中，我们朝着了解菌群的作用方面取得了长足的进步（菌群（The） 人体中居住在人体中的微生物数万亿微生物（其基因）。 单个微生物或病毒病原体与许多癌症的病因相关，包括胃，结肠，结肠。 和宫颈癌。 代谢活动，宿主的基因型和免疫系统活动，以及宿主饮食，当前和电流等因素 以前的吸烟状况和环境暴露。 我们建议推进癌症微生物组研究三个特定目标。 在流行的Qiime 2微生物组生物信息学平台和Qiita公共微生物组数据的背景下 存储库和汇总分析系统。 生物信息学方法和数据通过创建Qiime 2的星系界面，改进了Fort Fort Fort fort fort fort fort fort fort fort fort fort fort fort fort fort for 与Qiime 2在R编程语言和GARAXY GUI生态系统中合作，以癌症流行 研究，开发癌症微生物组汇总分析的资源，癌症的发展 专注的微生物组生物信息学研讨会系列，并通过制作Qiime 2和癌症微生物组数据 可从NCI类资源中访问。 由癌症研究界Qiime 2的需求驱动的生物信息学平台2 用于代谢组学，元文字组学，宏基因组学和元蛋白质组学的插件，开发人员正在 在这些重要的癌症微生物组项目中，通过整合这些不同的 数据类型，但无能为力的技术仍然可以使麦芽词生物信息学 所有项目都可以从这些方法中受益。 按照我们最近的模型，创建微生物组多摩斯生物信息学开发人员会议 教学和发展Qiime 2会议。 微生物组生物信息学方法，以及癌症微生物组生物信息学的可靠性，由BYE BYE 扩展与Qiime 2中跟踪数据Provence相关的切断，并帮助用户提交他们的 微生物组多摩斯原始数据到档案存储库。 癌症研究的信息技术（ITCR）和云资源项目团队，其中一些 我们我们开始与之合作。